OncoCyte (OCX) Stock Chart & Stock Price History $2.64 -0.13 (-4.69%) As of 03:38 PM Eastern Add Compare Share Share Chart Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrendsBuy This Stock OncoCyte Stock Price Performance The OncoCyte (OCX) stock chart highlights key performance trends across multiple timeframes. Over the last 12 months, the stock's price has decreased 8.97%, with a year-to-date return of 10.92%. In the past month, the stock has decreased 7.37%, reflecting recent market activity. As of the latest close, OncoCyte traded at $2.77 with a market cap of $79.22 million and volume of 49,582 shares. Five years ago, the stock traded at a split-adjusted price of $57.40, representing a 95.40% decrease over that period. At the time, it had a market cap of $173.05 million and a volume of 30,890 shares. Receive OCX Stock News and Ratings via EmailSign-up to receive the latest news and ratings for OncoCyte and its competitors with MarketBeat's FREE daily newsletter. Email Address 5 Day Performance-8.01%1 Month Performance-7.37%3 Month Performance+3.13%Year-To-Date Performance+10.92%1 Year Performance-8.97%5 Year Performance-95.40% OCX Stock Chart for Wednesday, May, 14, 2025 OCX Chart by TradingView OncoCyte Stock Price History Daily Weekly Monthly Yearly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 3 Year 5 Year Time Frame * Start Date * End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization05/13/2025$2.81$2.77-1.42%$2.82$2.5749,582 shs$79.22 million05/12/2025$2.87$2.81-2.09%$3.06$2.6464,472 shs$80.36 million05/09/2025$2.83$2.87+1.41%$2.96$2.8162,571 shs$82.08 million05/08/2025$2.83$2.83+0.07%$2.89$2.7922,752 shs$80.94 million05/07/2025$2.89$2.83-2.15%$2.94$2.7826,673 shs$80.88 million05/06/2025$2.92$2.89-1.03%$3.32$2.80141,220 shs$82.65 million05/05/2025$3.03$2.92-3.63%$3.11$2.8915,015 shs$83.51 million05/02/2025$3.10$3.03-2.26%$3.10$3.0013,235 shs$86.66 million05/01/2025$3.08$3.10+0.65%$3.18$2.8743,070 shs$88.66 million04/30/2025$3.12$3.08-1.28%$3.25$3.0861,598 shs$88.09 million Get the Latest News and Ratings for OCX and Related StocksEnter your email address below to receive the latest news and analysts' ratings for OncoCyte and its competitors with MarketBeat's FREE daily newsletter. 04/29/2025$3.22$3.12-3.11%$3.35$3.1019,472 shs$89.23 million04/28/2025$3.44$3.22-6.40%$3.44$3.1924,160 shs$92.09 million04/25/2025$3.39$3.44+1.47%$3.50$3.2688,149 shs$98.38 million04/24/2025$2.95$3.39+14.92%$3.44$3.05169,400 shs$96.95 million04/23/2025$2.92$2.95+1.03%$3.03$2.8228,043 shs$84.37 million04/22/2025$2.88$2.92+1.39%$3.08$2.7882,068 shs$83.51 million04/21/2025$2.84$2.88+1.41%$2.92$2.787,789 shs$82.37 million04/18/2025$2.84$2.84$2.85$2.768,001 shs$81.22 million04/17/2025$2.83$2.84+0.35%$2.85$2.768,001 shs$81.22 million04/16/2025$2.94$2.83-3.74%$2.95$2.8019,903 shs$80.94 million04/15/2025$2.85$2.94+3.16%$3.08$2.9225,484 shs$84.08 million04/14/2025$2.78$2.85+2.52%$2.92$2.7616,505 shs$81.51 million Related Companies Solid Biosciences Stock Price Chart Heron Therapeutics Stock Price Chart Arcturus Therapeutics Stock Price Chart Cartesian Therapeutics Stock Price Chart Alpha Teknova Stock Price Chart Septerna Stock Price Chart Atyr PHARMA Stock Price Chart Fulcrum Therapeutics Stock Price Chart Aura Biosciences Stock Price Chart Atai Life Sciences Stock Price Chart Receive OCX Stock News and Ratings via EmailSign-up to receive the latest news and ratings for OncoCyte and its competitors with MarketBeat's FREE daily newsletter. This page (NASDAQ:OCX) was last updated on 5/14/2025 by MarketBeat.com Staff From Our PartnersWatch This Robotics Demo Before July 23rdJeff Brown, the tech legend who picked shares of Nvidia in 2016 before they jumped by more than 22,000%... ...Brownstone Research | SponsoredSilver Demand Is Soaring-Supply Can't Keep UpSilver demand hit 1.16 billion ounces in 2024-while supply fell short again for the fourth year in a row. I...i2i Marketing Group, LLC | SponsoredThis Signal Only Flashes Once Every 4 Years – And It Just TriggeredThis same signal has appeared twice before in the past 8 years — both times, it kicked off major moves in cryp...Crypto Swap Profits | SponsoredTrump wipes out trillions overnight…Is there anybody more powerful than Donald Trump right now? In a single tariff announcement, he wiped out n...Porter & Company | SponsoredTake a look at this picture ...A strange investment secret — discovered just a few short weeks before this image was taken — correctly predic...Weiss Ratings | SponsoredSilicon Valley Gold RushA new technology has sparked a modern-day gold rush in Silicon Valley. OpenAI’s Sam Altman invested $375M. Bil...Stansberry Research | Sponsored“America is running out of power” - The Washington PostAccording to The Washington Post, AI is causing America to “run out of power”... It’s true — utility compan...True Market Insiders | SponsoredTrump Made a Deal. Your Retirement Could Still Be in Danger.America is still barreling toward a financial cliff. This isn't political. It's mathematical. And no trade ...Lear Capital | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding OncoCyte Co. Please log in to your account or sign up in order to add this asset to your watchlist. Share OncoCyte With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy OCX Stock Free OCX Stock Alerts